{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T11:44:36Z","timestamp":1795088676242,"version":"4.10.2"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T00:00:00Z","timestamp":1681689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T00:00:00Z","timestamp":1681689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Legal Med"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s00414-023-02996-1","type":"journal-article","created":{"date-parts":[[2023,4,16]],"date-time":"2023-04-16T22:01:55Z","timestamp":1681682515000},"page":"1023-1037","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Adverse events of clenbuterol among athletes: a systematic review of case reports and case series"],"prefix":"10.1007","volume":"137","author":[{"given":"Sweta","family":"Kumari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biplab","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeev Kumar","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranav Kumar","family":"Prabhakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5125-3791","authenticated-orcid":false,"given":"Devesh","family":"Tewari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,17]]},"reference":[{"key":"2996_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jas\/skab116","volume":"99","author":"JH Hwang","year":"2021","unstructured":"Hwang JH, Spurlock ME, Kube JC, Li XZ, Smith SB (2021) Characterization of \u03b2-adrenergic receptors in bovine intramuscular and subcutaneous adipose tissue: comparison of lubabegron fumarate with \u03b2-adrenergic receptor agonists and antagonists. J Anim Sci 99:1\u201312. https:\/\/doi.org\/10.1093\/jas\/skab116","journal-title":"J Anim Sci"},{"key":"2996_CR2","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s13105-010-0024-8","volume":"66","author":"H-K Kim","year":"2010","unstructured":"Kim H-K, Della-Fera MA, Hausman DB, Baile CA (2010) Effect of clenbuterol on apoptosis, adipogenesis, and lipolysis in adipocytes. J Physiol Biochem 66:197\u2013203. https:\/\/doi.org\/10.1007\/s13105-010-0024-8","journal-title":"J Physiol Biochem"},{"key":"2996_CR3","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1248\/bpb1978.8.385","volume":"8","author":"I Yamamoto","year":"1985","unstructured":"Yamamoto I, Iwata K, Nakashima M (1985) Pharmacokinetics of plasma and urine clenbuterol in man, rat, and rabbit. J Pharmacobiodyn 8:385\u2013391. https:\/\/doi.org\/10.1248\/bpb1978.8.385","journal-title":"J Pharmacobiodyn"},{"key":"2996_CR4","doi-asserted-by":"crossref","unstructured":"Al-Majed AA, Khalil NY, Khbrani I, Abdel-Aziz HA (2017) Clenbuterol hydrochloride. profiles of drug substances, excipients and related methodology. Elsevier. 91\u2013123.","DOI":"10.1016\/bs.podrm.2017.02.002"},{"key":"2996_CR5","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1016\/j.jemermed.2015.09.006","volume":"50","author":"NM Grimmer","year":"2016","unstructured":"Grimmer NM, Gimbar RP, Bursua A, Patel M (2016) Rhabdomyolysis secondary to clenbuterol use and exercise. J Emerg Med 50:e71\u2013e74. https:\/\/doi.org\/10.1016\/j.jemermed.2015.09.006","journal-title":"J Emerg Med"},{"key":"2996_CR6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/0093-691X(80)90131-4","volume":"14","author":"K Zerobin","year":"1980","unstructured":"Zerobin K, K\u00fcndig H (1980) The control of myometrial functions during parturition with A\u03b22-mimeticcompound, PlanipartR. Theriogenology 14:21\u201335. https:\/\/doi.org\/10.1016\/0093-691X(80)90131-4","journal-title":"Theriogenology"},{"key":"2996_CR7","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1080\/08897077.2013.772083","volume":"34","author":"HA Spiller","year":"2013","unstructured":"Spiller HA, James KJ, Scholzen S, Borys DJ (2013) A descriptive study of adverse events from clenbuterol misuse and abuse for weight loss and bodybuilding. Subst Abuse 34:306\u2013312. https:\/\/doi.org\/10.1080\/08897077.2013.772083","journal-title":"Subst Abuse"},{"key":"2996_CR8","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/bf03160909","volume":"3","author":"GP Daubert","year":"2007","unstructured":"Daubert GP, Mabasa VH, Leung VW, Aaron C (2007) Acute clenbuterol overdose resulting in supraventricular tachycardia and atrial fibrillation. J Med Toxicol 3:56\u201360. https:\/\/doi.org\/10.1007\/bf03160909","journal-title":"J Med Toxicol"},{"key":"2996_CR9","doi-asserted-by":"publisher","first-page":"bcr0820080708","DOI":"10.1136\/bcr.08.2008.0708","volume":"2009","author":"J Young","year":"2009","unstructured":"Young J, Anwar A (2009) Strong diabetes. BMJ Case Rep 2009:bcr0820080708. https:\/\/doi.org\/10.1136\/bcr.08.2008.0708","journal-title":"BMJ Case Rep"},{"key":"2996_CR10","doi-asserted-by":"publisher","first-page":"bcr2016215157","DOI":"10.1136\/2Fbcr-2016-215157","volume":"2016","author":"M Waight","year":"2016","unstructured":"Waight M, McGuinness W (2016) Case of low dose clenbuterol toxicity. BMJ Case Rep 2016:bcr2016215157. https:\/\/doi.org\/10.1136\/2Fbcr-2016-215157","journal-title":"BMJ Case Rep"},{"key":"2996_CR11","unstructured":"WADA prohibited list January 2020. Available online: https:\/\/www.wada-ama.org\/sites\/default\/files\/wada_2020_english_prohibited_list_0.pdf (access on 30.12.2021). pp. WADA antidoping agency."},{"key":"2996_CR12","unstructured":"Prohibited and restricted drugs in food animals. pp. Food Animal Residue Avoidance Databank."},{"key":"2996_CR13","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/bmc.928","volume":"22","author":"MK Parr","year":"2008","unstructured":"Parr MK, Koehler K, Geyer H, Guddat S, Sch\u00e4nzer W (2008) Clenbuterol marketed as dietary supplement. Biomed Chromatogr 22:298\u2013300. https:\/\/doi.org\/10.1002\/bmc.928","journal-title":"Biomed Chromatogr"},{"key":"2996_CR14","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.jemermed.2016.05.047","volume":"51","author":"MA Hieger","year":"2016","unstructured":"Hieger MA, Emswiler MP, Maskell KF et al (2016) A case series of clenbuterol toxicity caused by adulterated heroin. J Emerg Med 51:259\u2013261. https:\/\/doi.org\/10.1016\/j.jemermed.2016.05.047","journal-title":"J Emerg Med"},{"key":"2996_CR15","unstructured":"Moriarty N, Attar N (2020) Clenbuterol-induced myocarditis: a case report. Eur J Case Rep Intern Med 7. 10.12890%2F2020_001662"},{"key":"2996_CR16","doi-asserted-by":"publisher","first-page":"219","DOI":"10.5694\/mja13.10982","volume":"200","author":"J Brett","year":"2014","unstructured":"Brett J, Dawson AH, Brown JA (2014) Clenbuterol toxicity: a NSW poisons information centre experience. Med J Aust 200:219\u2013221. https:\/\/doi.org\/10.5694\/mja13.10982","journal-title":"Med J Aust"},{"key":"2996_CR17","first-page":"269","volume":"44","author":"T Gojmerac","year":"2002","unstructured":"Gojmerac T, Pleadin J, Zuric M, Mirko L, Stipica C (2002) Effects of repeated growth-promoting doses of clenbuterol on the hepatic function of female pigs. Vet Hum Toxicol 44:269\u2013271","journal-title":"Vet Hum Toxicol"},{"key":"2996_CR18","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1152\/japplphysiol.00139.2002","volume":"93","author":"JG Burniston","year":"2002","unstructured":"Burniston JG, Ng Y, Clark WA, Colyer J, Tan L-B, Goldspink DF (2002) Myotoxic effects of clenbuterol in the rat heart and soleus muscle. J Appl Physiol 93:1824\u20131832. https:\/\/doi.org\/10.1152\/japplphysiol.00139.2002","journal-title":"J Appl Physiol"},{"key":"2996_CR19","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.saa.2012.12.017","volume":"105","author":"J Chai","year":"2013","unstructured":"Chai J, Xu Q, Dai J, Liu R (2013) Investigation on potential enzyme toxicity of clenbuterol to trypsin. Spectrochim Acta A Mol Biomol Spectrosc 105:200\u2013206. https:\/\/doi.org\/10.1016\/j.saa.2012.12.017","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"key":"2996_CR20","doi-asserted-by":"publisher","first-page":"466","DOI":"10.3389\/fphar.2019.00466","volume":"10","author":"D Tewari","year":"2019","unstructured":"Tewari D, Samoil\u0103 O, Gocan D et al (2019) Medicinal plants and natural products used in cataract management. Front Pharmacol 10:466. https:\/\/doi.org\/10.3389\/fphar.2019.00466","journal-title":"Front Pharmacol"},{"key":"2996_CR21","volume-title":"Background document: explanation of the 2011 Oxford Centre for Evidence-Based Medicine (OCEBM) levels of evidence","author":"J Howick","year":"2011","unstructured":"Howick J, Chalmers I, Glasziou P et al (2011) Background document: explanation of the 2011 Oxford Centre for Evidence-Based Medicine (OCEBM) levels of evidence. University of Oxford, Centre for Evidence-Based Medicine, Oxford, UK"},{"key":"2996_CR22","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1136\/bmjebm-2017-110853","volume":"23","author":"MH Murad","year":"2018","unstructured":"Murad MH, Sultan S, Haffar S, Bazerbachi F (2018) Methodological quality and synthesis of case series and case reports. BMJ Evid-Based Med 23:60\u201363. https:\/\/doi.org\/10.1136\/bmjebm-2017-110853","journal-title":"BMJ Evid-Based Med"},{"key":"2996_CR23","unstructured":"Report on medicines use during COVID-19 Pandemic, July 2020. Avalable online: https:\/\/www.aifa.gov.it\/documents\/20142\/1202341\/OsMedCovidEng.pdf (access on 04.02.22)."},{"key":"2996_CR24","unstructured":"New drug approval 2016. available online:https:\/\/newdrugapprovals.org\/2016\/10\/03\/clenbuterol\/ (access on 05.02.23) pp. Clenbuterol is approved in Germany for the treatment of asthma and COPD."},{"key":"2996_CR25","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1253\/circj.69.1144","volume":"69","author":"B Kierzkowska","year":"2005","unstructured":"Kierzkowska B, Stanczyk J, Kasprzak JD (2005) Myocardial infarction in a 17-year-old body builder using clenbuterol. Circ J 69:1144\u20131146. https:\/\/doi.org\/10.1253\/circj.69.1144","journal-title":"Circ J"},{"key":"2996_CR26","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1080\/02652030500135102","volume":"22","author":"J Barbosa","year":"2005","unstructured":"Barbosa J, Cruz C, Martins J et al (2005) Food poisoning by clenbuterol in Portugal. Food Addit Contam 22:563\u2013566. https:\/\/doi.org\/10.1080\/02652030500135102","journal-title":"Food Addit Contam"},{"key":"2996_CR27","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0378-4274(99)00270-2","volume":"114","author":"G Brambilla","year":"2000","unstructured":"Brambilla G, Cenci T, Franconi F et al (2000) Clinical and pharmacological profile in a clenbuterol epidemic poisoning of contaminated beef meat in Italy. Toxicol Lett 114:47\u201353","journal-title":"Toxicol Lett"},{"key":"2996_CR28","doi-asserted-by":"publisher","first-page":"100281","DOI":"10.1371\/journal.pone.0100281","volume":"9","author":"P Sirvent","year":"2014","unstructured":"Sirvent P, Douillard A, Galbes O et al (2014) Effects of chronic administration of clenbuterol on contractile properties and calcium homeostasis in rat extensor digitorum longus muscle. PLoS One 9:100281. https:\/\/doi.org\/10.1371\/journal.pone.0100281","journal-title":"PLoS One"},{"key":"2996_CR29","doi-asserted-by":"publisher","first-page":"842","DOI":"10.2460\/javma.239.6.842","volume":"239","author":"JA Thompson","year":"2011","unstructured":"Thompson JA, Mirza MH, Barker SA, Morgan TW, Bauer RW, McConnico RS (2011) Clenbuterol toxicosis in three Quarter Horse racehorses after administration of a compounded product. J Am Vet Med Assoc 239:842\u2013849. https:\/\/doi.org\/10.2460\/javma.239.6.842","journal-title":"J Am Vet Med Assoc"},{"key":"2996_CR30","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1016\/S0735-1097(19)33465-5","volume":"73","author":"L Njoroge","year":"2019","unstructured":"Njoroge L, Koromia GA, Patel B (2019) Myocardial infarction associated with clenbuterol abuse in a 22-year-old college athlete. J Am Coll Cardiol 73:2859. https:\/\/doi.org\/10.1016\/S0735-1097(19)33465-5","journal-title":"J Am Coll Cardiol"},{"key":"2996_CR31","doi-asserted-by":"publisher","unstructured":"Bonnar CE, Brazil JF, Okiro JO et al (2021) Making weight: acute muscle weakness and hypokalaemia exacerbated by thyrotoxicosis factitia in a bodybuilder. Endocrinol Diabetes Metab Case Rep 2021. https:\/\/doi.org\/10.1530\/edm-21-0060","DOI":"10.1530\/edm-21-0060"},{"key":"2996_CR32","doi-asserted-by":"publisher","first-page":"316","DOI":"10.5935\/2Fabc.20150111","volume":"105","author":"RP Santos","year":"2015","unstructured":"Santos RP, Pereira A, Guedes H, Louren\u00e7o C, Azevedo J, Pinto P (2015) Anabolic drugs and myocardial infarction\u2013a clinical case report. Arq Bras Cardiol 105:316\u20139. https:\/\/doi.org\/10.5935\/2Fabc.20150111","journal-title":"Arq Bras Cardiol"},{"key":"2996_CR33","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.jemermed.2012.02.057","volume":"44","author":"DS Huckins","year":"2013","unstructured":"Huckins DS, Lemons MF (2013) Myocardial ischemia associated with clenbuterol abuse: report of two cases. J Emerg Med 44:444\u2013449. https:\/\/doi.org\/10.1016\/j.jemermed.2012.02.057","journal-title":"J Emerg Med"},{"key":"2996_CR34","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1002\/mus.20407","volume":"32","author":"JG Burniston","year":"2005","unstructured":"Burniston JG, Chester N, Clark WA, Tan LB, Goldspink DF (2005) Dose-dependent apoptotic and necrotic myocyte death induced by the \u03b22-adrenergic receptor agonist, clenbuterol. Muscle Nerve 32:767\u2013774. https:\/\/doi.org\/10.1002\/mus.20407","journal-title":"Muscle Nerve"},{"key":"2996_CR35","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1152\/physrev.00045.2006","volume":"88","author":"DJ Duncker","year":"2008","unstructured":"Duncker DJ, Bache RJ (2008) Regulation of coronary blood flow during exercise. Physiol Rev 88:1009\u20131086. https:\/\/doi.org\/10.1152\/physrev.00045.2006","journal-title":"Physiol Rev"},{"key":"2996_CR36","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1016\/j.fct.2007.03.002","volume":"45","author":"G Mazzanti","year":"2007","unstructured":"Mazzanti G, Di Sotto A, Daniele C et al (2007) A pharmacodynamic study on clenbuterol-induced toxicity: \u03b21-and \u03b22-adrenoceptors involvement in guinea-pig tachycardia in an in vitro model. Food Chem Toxicol 45:1694\u20131699. https:\/\/doi.org\/10.1016\/j.fct.2007.03.002","journal-title":"Food Chem Toxicol"},{"key":"2996_CR37","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1097\/00007611-199808000-00019","volume":"91","author":"DR Goldstein","year":"1998","unstructured":"Goldstein DR, Dobbs T, Krull B, Plumb VJ (1998) DECA-it\u2019s what\u2019s for dinner. South Med J 91:780\u2013784","journal-title":"South Med J"},{"key":"2996_CR38","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1081\/clt-100105152","volume":"39","author":"RJ Hoffman","year":"2001","unstructured":"Hoffman RJ, Hoffman RS, Freyberg CL, Poppenga RH, Nelson LS (2001) Clenbuterol ingestion causing prolonged tachycardia, hypokalemia, and hypophosphatemia with confirmation by quantitative levels. J Toxicol Clin Toxicol 39:339\u2013344. https:\/\/doi.org\/10.1081\/clt-100105152","journal-title":"J Toxicol Clin Toxicol"},{"key":"2996_CR39","first-page":"233","volume":"18","author":"N El-Sherif","year":"2011","unstructured":"El-Sherif N, Turitto G (2011) Electrolyte disorders and arrhythmogenesis. Cardiol J 18:233\u2013245","journal-title":"Cardiol J"},{"key":"2996_CR40","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1093\/jat\/bkz058","volume":"43","author":"P Kintz","year":"2019","unstructured":"Kintz P, Gheddar L, Ameline A et al (2019) Complete post-mortem investigations in a death involving clenbuterol after long-term abuse. J Anal Toxicol 43:660\u2013665. https:\/\/doi.org\/10.1093\/jat\/bkz058","journal-title":"J Anal Toxicol"},{"key":"2996_CR41","doi-asserted-by":"publisher","first-page":"109925","DOI":"10.1016\/j.forsciint.2019.109925","volume":"303","author":"S Lehmann","year":"2019","unstructured":"Lehmann S, Thomas A, Schiwy-Bochat K-H et al (2019) Death after misuse of anabolic substances (clenbuterol, stanozolol and metandienone). Forensic Sci Int 303:109925. https:\/\/doi.org\/10.1016\/j.forsciint.2019.109925","journal-title":"Forensic Sci Int"},{"key":"2996_CR42","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s004140050165","volume":"111","author":"R Hausmann","year":"1998","unstructured":"Hausmann R, Hammer S, Betz P (1998) Performance enhancing drugs (doping agents) and sudden death\u2013a case report and review of the literature. Int J Legal Med 111:261\u2013264. https:\/\/doi.org\/10.1007\/s004140050165","journal-title":"Int J Legal Med"},{"key":"2996_CR43","doi-asserted-by":"publisher","first-page":"197","DOI":"10.5811\/2Fcpcem.2017.2.33318","volume":"1","author":"MK Griswold","year":"2017","unstructured":"Griswold MK, Blohm E, Cross R, Boyer EW, Carey JL (2017) Unsuspected clenbuterol toxicity in a patient using intramuscular testosterone. Clin Pract Cases Emerg Med 1:197. https:\/\/doi.org\/10.5811\/2Fcpcem.2017.2.33318","journal-title":"Clin Pract Cases Emerg Med"},{"key":"2996_CR44","doi-asserted-by":"publisher","first-page":"469","DOI":"10.4158\/ep08331.rar","volume":"15","author":"JN Clore","year":"2009","unstructured":"Clore JN, Thurby-Hay L (2009) Glucocorticoid-induced hyperglycemia. Endocr Pract 15:469\u2013474. https:\/\/doi.org\/10.4158\/ep08331.rar","journal-title":"Endocr Pract"},{"key":"2996_CR45","first-page":"2521","volume":"123","author":"J Illera","year":"1998","unstructured":"Illera J, Mart\u00ddnez M (1998) The effect of clenbuterol on adrenal function in rats. Anlst 123:2521\u20132524","journal-title":"Anlst"},{"key":"2996_CR46","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.2741\/e569","volume":"4","author":"Q Liu","year":"2012","unstructured":"Liu Q, Zhang J, Guo W, Zhao Y, Hu X, Li N (2012) Identifying lipid metabolism genes in pig liver after clenbuterol administration. Front Biosci (Elite Ed) 4:2605\u20132616. https:\/\/doi.org\/10.2741\/e569","journal-title":"Front Biosci (Elite Ed)"},{"key":"2996_CR47","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1177\/0897190018823114","volume":"33","author":"J Woolum","year":"2020","unstructured":"Woolum J, Mancuso N, Rutter PW, Baum RA, Akpunonu P (2020) Chomping at the bit: a descriptive report on pediatric clenbuterol ingestion. J Pharm Pract 33:386\u2013389. https:\/\/doi.org\/10.1177\/0897190018823114","journal-title":"J Pharm Pract"},{"key":"2996_CR48","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1016\/j.jemermed.2019.06.016","volume":"57","author":"CF Bonney","year":"2019","unstructured":"Bonney CF, Hatten B, Wang GS (2019) Toxicity from unintentional pediatric ingestion of a performance-enhancing drug: a case report with review of clenbuterol toxicity and treatment. J Emerg Med 57:e105\u2013e108. https:\/\/doi.org\/10.1016\/j.jemermed.2019.06.016","journal-title":"J Emerg Med"},{"key":"2996_CR49","doi-asserted-by":"publisher","first-page":"254","DOI":"10.17235\/reed.2017.5103\/2017","volume":"110","author":"P Mascagni","year":"2018","unstructured":"Mascagni P, Melandro F, Larghi-Laureiro Z, Mennini G, Rossi M (2018) Spontaneous hepatic rupture in a bodybuilder: a case report and review of the literature. Rev Esp Enferm Dig 110:254\u20136. https:\/\/doi.org\/10.17235\/reed.2017.5103\/2017","journal-title":"Rev Esp Enferm Dig"},{"key":"2996_CR50","unstructured":"Abdulredha WS (2019) Effect of clenbuterol using as weight loose on liver enzymes and lipids profile. Iraq Med J 3."},{"key":"2996_CR51","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1093\/ndt\/16.1.163","volume":"16","author":"R Hartung","year":"2001","unstructured":"Hartung R, Gerth J, F\u00fcnfst\u00fcck R, Gr\u00f6ne HJ, Stein G (2001) End-stage renal disease in a bodybuilder: a multifactorial process or simply doping? Nephrol Dial Transplant 16:163\u2013165. https:\/\/doi.org\/10.1093\/ndt\/16.1.163","journal-title":"Nephrol Dial Transplant"},{"key":"2996_CR52","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1007\/s00414-020-02268-2","volume":"134","author":"L Dufayet","year":"2020","unstructured":"Dufayet L, Gorgiard C, Vayssette F, Barbet J, Hoizey G, Ludes B (2020) Death of an apprentice bodybuilder following 2, 4-dinitrophenol and clenbuterol intake. Int J Legal Med 134:1003\u20131006. https:\/\/doi.org\/10.1007\/s00414-020-02268-2","journal-title":"Int J Legal Med"},{"key":"2996_CR53","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1093\/jat\/bkaa121","volume":"44","author":"DM Boland","year":"2020","unstructured":"Boland DM (2020) Disposition of toxic drugs and chemicals in man, 12th Edition. J Anal Toxicol 44:e13-e. https:\/\/doi.org\/10.1093\/jat\/bkaa121","journal-title":"J Anal Toxicol"},{"key":"2996_CR54","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/bms.1200190206","volume":"19","author":"J Girault","year":"1990","unstructured":"Girault J, Gobin P, Fourtillan J (1990) Quantitative measurement of clenbuterol at the femtomole level in plasma and urine by combined gas chromatography\/negative ion chemical ionization mass spectrometry. Biomed Environ Mass Spectrom 19:80\u201388","journal-title":"Biomed Environ Mass Spectrom"},{"key":"2996_CR55","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1016\/j.ajem.2015.12.086","volume":"34","author":"KE Quinley","year":"2016","unstructured":"Quinley KE, Chen H-Y, Yang HS, Lynch KL, Olson KR (2016) Clenbuterol causing non\u2013ST-segment elevation myocardial infarction in a teenage female desiring to lose weight: case and brief literature review. Am J Emerg Med 34:1739","journal-title":"Am J Emerg Med"},{"key":"2996_CR56","unstructured":"World Anti-Doping Agency (WADA) World anti-doping code 2015 (with 2019 Amendments) (access on 01.February 2023)."},{"key":"2996_CR57","unstructured":"World Anti-Doping Ageny (WADA). Stakeholder notice regarding meat contamination. 2019. Available online: http:\/\/www.wada-ama.org\/sites\/default\/files\/resources\/files\/2019-05-30-meat_contamination_notice_final.pdf (Access on 01.02.23)."},{"key":"2996_CR58","doi-asserted-by":"publisher","first-page":"118","DOI":"10.2746\/0425164044868620","volume":"36","author":"A Schlupp","year":"2004","unstructured":"Schlupp A, Anielski P, Thieme D, M\u00fcller R, Meyer H, Ellendorff F (2004) The \u03b2-agonist clenbuterol in mane and tail hair of horses. Equine Vet J 36:118\u2013122","journal-title":"Equine Vet J"},{"key":"2996_CR59","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1093\/clinchem\/42.11.1869","volume":"42","author":"A Gleixner","year":"1996","unstructured":"Gleixner A, Sauerwein H, Meyer H (1996) Detection of the anabolic beta 2-adrenoceptor agonist clenbuterol in human scalp hair by HPLC\/EIA. Clin Chem 42:1869\u20131871","journal-title":"Clin Chem"},{"key":"2996_CR60","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1093\/anatox\/35.8.566","volume":"35","author":"A Vuli\u0107","year":"2011","unstructured":"Vuli\u0107 A, Pleadin J, Per\u0161i N, Stojkovi\u0107 R, Ivankovi\u0107 S (2011) Accumulation of \u03b2-agonists clenbuterol and salbutamol in black and white mouse hair. J Anal Toxicol 35:566\u2013570","journal-title":"J Anal Toxicol"},{"key":"2996_CR61","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1002\/dta.1746","volume":"6","author":"A Krumbholz","year":"2014","unstructured":"Krumbholz A, Anielski P, Gfrerer L et al (2014) Statistical significance of hair analysis of clenbuterol to discriminate therapeutic use from contamination. Drug Test Anal 6:1108\u20131116","journal-title":"Drug Test Anal"},{"key":"2996_CR62","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0378-4347(98)00527-1","volume":"723","author":"M Machnik","year":"1999","unstructured":"Machnik M, Geyer H, Horning S, Breidbach A, Delahaut P, Sch\u00e4nzer W (1999) Long-term detection of clenbuterol in human scalp hair by gas chromatography\u2013high-resolution mass spectrometry. J Chromatogr B Biomed Sci Appl 723:147\u2013155","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"2996_CR63","unstructured":"WADA 2012 anti-doping testing figures. Available online:https:\/\/www.wada-ama.org\/sites\/default\/files\/resources\/files\/2012_anti-doping_testing_figures_en.pdf (Access on 02.02.2023)."},{"key":"2996_CR64","unstructured":"WADA 2013 anti-doping testing figures. Available online:https:\/\/www.wada-ama.org\/sites\/default\/files\/resources\/files\/2013_anti-doping_testing_figures_en.pdf (Access on 02.02.2023)."},{"key":"2996_CR65","unstructured":"WADA 2014 anti-doping testing figures. Available online:https:\/\/www.wada-ama.org\/sites\/default\/files\/resources\/files\/2014_anti-doping_testing_figures_en.pdf (Access on 02.02.2023)."},{"key":"2996_CR66","unstructured":"WADA 2015 anti-doping testing figures. Available online:https:\/\/www.wada-ama.org\/sites\/default\/files\/resources\/files\/2015_anti-doping_testing_figures_en.pdf (Access on 02.02.2023)."},{"key":"2996_CR67","unstructured":"WADA 2016 anti-doping testing figures. Available online:https:\/\/www.wada-ama.org\/sites\/default\/files\/resources\/files\/2016_anti-doping_testing_figures_en.pdf (Access on 02.02.2023)."},{"key":"2996_CR68","unstructured":"WADA 2017 anti-doping testing figures. Available online:https:\/\/www.wada-ama.org\/sites\/default\/files\/resources\/files\/2017_anti-doping_testing_figures_en.pdf (Access on 02.02.2023)."},{"key":"2996_CR69","unstructured":"WADA 2018 anti-doping testing figures. Available online: https:\/\/www.wada-ama.org\/sites\/default\/files\/resources\/files\/2018_testing_figures_report.pdf (Access on 02.02.2023)."},{"key":"2996_CR70","unstructured":"WADA 2019 anti-doping testing figures. Available online:https:\/\/www.wada-ama.org\/sites\/default\/files\/resources\/files\/2019_anti-doping_testing_figures_en.pdf (Access on 02.02.2023)."},{"key":"2996_CR71","unstructured":"WADA 2020 anti-doping testing figures. Available online:https:\/\/www.wada-ama.org\/sites\/default\/files\/resources\/files\/2020_anti-doping_testing_figures_en.pdf (Access on 02.02.2023)."},{"key":"2996_CR72","unstructured":"WADA 2021 anti-doping testing figures. https:\/\/www.wada-ama.org\/sites\/default\/files\/2023-01\/2021_anti-doping_testing_figures_en.pdf."},{"key":"2996_CR73","doi-asserted-by":"publisher","first-page":"100319","DOI":"10.1016\/j.aqrep.2020.100319","volume":"17","author":"RA Mohamed","year":"2020","unstructured":"Mohamed RA, Elbialy ZI, Abd El Latif AS et al (2020) Dietary clenbuterol modifies the expression of genes involved in the regulation of lipid metabolism and growth in the liver, skeletal muscle, and adipose tissue of Nile tilapia (Oreochromis niloticus). Aquac Rep 17:100319. https:\/\/doi.org\/10.1016\/j.aqrep.2020.100319","journal-title":"Aquac Rep"},{"key":"2996_CR74","unstructured":"Performance and image enhancing drugs July 2019. Available online: https:\/\/www.tga.gov.au\/news\/news\/performance-and-image-enhancing-drugs (Access on 05.02.23)."},{"key":"2996_CR75","doi-asserted-by":"publisher","first-page":"529","DOI":"10.15171\/apb.2018.062","volume":"8","author":"RA Vlad","year":"2018","unstructured":"Vlad RA, Hancu G, Popescu GC, Lungu IA (2018) Doping in sports, a never-ending story? Adv Pharm Bull 8:529","journal-title":"Adv Pharm Bull"},{"key":"2996_CR76","unstructured":"Clenbuterol - DEA diversion control division. available online: https:\/\/www.deadiversion.usdoj.gov\/drug_chem_info\/clenbuterol.pdf (access on 29.07.22)."},{"key":"2996_CR77","doi-asserted-by":"publisher","DOI":"10.1007\/s13181-010-0010-0","volume-title":"Adulterated cocaine and lessons learned from the Jake walk blues","author":"TJ Wiegand","year":"2010","unstructured":"Wiegand TJ (2010) Adulterated cocaine and lessons learned from the Jake walk blues. Springer"},{"key":"2996_CR78","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1080\/11358120809487637","volume":"6","author":"M Estrada-Montoya","year":"2008","unstructured":"Estrada-Montoya M, Gonz\u00e1lez-C\u00f3rdova A, Torrescano G, Camou J, Vallejo-Cordoba B (2008) Screening and confirmatory determination of clenbuterol residues in bovine meat marketed in the Northwest of Mexico. Cienc Tecnol Aliment 6:130\u2013136. https:\/\/doi.org\/10.1080\/11358120809487637","journal-title":"Cienc Tecnol Aliment"},{"key":"2996_CR79","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13011-015-0006-5","volume":"10","author":"D Pino Scotto","year":"2015","unstructured":"Pino Scotto D (2015) Polypharmacy tra gli utenti di steroidi androgeni anabolizzanti: un metasynthesis descrittivo. Subst Abuse Treat Prev Policy 10:12. https:\/\/doi.org\/10.1186\/s13011-015-0006-5","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"2996_CR80","unstructured":"Hemery D, Ogden G, Evans A (1990) Winning without drugs: the natural approach to competitive sport. Willow."},{"key":"2996_CR81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13643-021-01626-4","volume":"10","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev 10:1\u201311","journal-title":"Syst Rev"},{"key":"2996_CR82","doi-asserted-by":"publisher","first-page":"4613","DOI":"10.1210\/jc.2013-2310","volume":"98","author":"NJ Perera","year":"2013","unstructured":"Perera NJ, Steinbeck KS, Shackel N (2013) The adverse health consequences of the use of multiple performance-enhancing substances\u2014a deadly cocktail. J Clin Endocrinol Metab 98:4613\u20134618. https:\/\/doi.org\/10.1210\/jc.2013-2310","journal-title":"J Clin Endocrinol Metab"},{"key":"2996_CR83","doi-asserted-by":"publisher","first-page":"bcr2015213836","DOI":"10.1136\/bcr-2015-213836","volume":"2016","author":"KN Mayer","year":"2016","unstructured":"Mayer KN, Wyder D, Spasic D, Herren T (2016) Severe rhinovirus pneumonia in a young woman taking performance-enhancing drugs. BMJ Case Rep 2016:bcr2015213836. https:\/\/doi.org\/10.1136\/bcr-2015-213836","journal-title":"BMJ Case Rep"},{"key":"2996_CR84","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1080\/15569543.2017.1348361","volume":"37","author":"N \u017dlak","year":"2018","unstructured":"\u017dlak N, Ko\u0161uta D, Potisek M, Stevanovi\u0107 \u017d (2018) Clenbuterol toxicity in a young male athlete. Toxin reviews 37:182\u2013186","journal-title":"Toxin reviews"},{"key":"2996_CR85","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1177\/1557988318783504","volume":"12","author":"C Li","year":"2018","unstructured":"Li C, Adhikari BK, Gao L et al (2018) Performance-enhancing drugs abuse caused cardiomyopathy and acute hepatic injury in a young bodybuilder. Am J Men\u2019s Health 12:1700\u20131704. https:\/\/doi.org\/10.1177\/1557988318783504","journal-title":"Am J Men's Health"},{"key":"2996_CR86","doi-asserted-by":"publisher","first-page":"186","DOI":"10.26502\/fccm.92920066","volume":"3","author":"A Shafrir","year":"2019","unstructured":"Shafrir A, Leibowitz DW, Alcalai R, Elitzur Y, Muszkat M (2019) Myocardial injury induced by the long acting beta2 adrenergic agonist clenbuterol. Cardiol Cardiovasc Med 3:186\u201392. https:\/\/doi.org\/10.26502\/fccm.92920066","journal-title":"Cardiol Cardiovasc Med"},{"key":"2996_CR87","unstructured":"CDSCO, Clenbuterol hydrochloride solution for injection 30mcg\/ml. https:\/\/cdscoonline.gov.in\/CDSCO\/Drugs. (access on 03.02.23)."},{"key":"2996_CR88","unstructured":"List of most commonly encountered drugs currently controlled under the misuse of drugs legislation 8 August 2022. Available online: https:\/\/www.gov.uk\/government\/publications\/controlled-drugs-list--2. (access on 23.09.22)."},{"key":"2996_CR89","unstructured":"(2022) Health Canada. Policy for the importation or sale of active pharmaceutical ingredients for veterinary use POL-0018. Available online: https:\/\/www.canada.ca\/content\/dam\/hc-sc\/migration\/hc-sc\/dhp-mps\/alt_formats\/hpfb-dgpsa\/pdf\/compli-conform\/pol_0018-eng.pdf (access on September 20122)."},{"key":"2996_CR90","unstructured":"China bans clenbuterol tablets. Available Online: https:\/\/www.thepigsite.com\/news\/2011\/10\/china-bans-clenbuterol-tablets-1#:~:text=CHINA%20%2D%20China%20has%20banned%20the,on%20Friday%20(30%20September) (access on 29.07.22)."}],"container-title":["International Journal of Legal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00414-023-02996-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00414-023-02996-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00414-023-02996-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T22:04:51Z","timestamp":1686175491000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00414-023-02996-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,17]]},"references-count":90,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["2996"],"URL":"https:\/\/doi.org\/10.1007\/s00414-023-02996-1","relation":{},"ISSN":["0937-9827","1437-1596"],"issn-type":[{"value":"0937-9827","type":"print"},{"value":"1437-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,17]]},"assertion":[{"value":"23 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}